Supplementary Tables 1 - 5 from Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization

PDF file - 150K, Relative binding affinity of anti-ErbB2 antibodies for the trastuzumab epitope on ErbB2 in BT-474 cells (S1); Relative binding affinity of anti-ErbB2 antibodies for the pertuzumab epitope on ErbB2 in BT-474 cells (S2); Binding affinities of recombinant anti-ErbB2 antibodies for ErbB2-ECD (S3); Pharmacokinetic parameters of recombinant anti-ErbB2 antibodies in mice (S4); ErbB receptor expression on breast cancer cell lines (S5).